Literature DB >> 8095982

90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.

C Natoli1, F Dianzani, F Mazzotta, E Balocchini, P Pierotti, G Antonelli, S Iacobelli.   

Abstract

A 90,000-Da molecular mass tumor-associated protein has recently been identified in the sera of patients infected by HIV. In this study, we have evaluated the serum levels of 90K for its ability to predict the progression to ARC or AIDS retrospectively in 49 HIV-seropositive subjects who were initially symptom-free. 90K levels were higher in those HIV-seropositive subjects who progressed to ARC or AIDS than in those who had not progressed both at entry into the study and at the latest visit. CD4+ cell number was not different in the two groups at entry but was lower in the progressors at the latest visit. Evaluation of the patterns of change over time showed that 90K increased and CD4+ cells decreased more in progressors than in nonprogressors. During the 3 years preceding the onset of ARC or AIDS, 90K increased regularly while CD4+ cell decrease was later. Elevated levels of 90K (p = 0.007) and lower numbers of CD4+ cells (p = 0.001) were significantly associated with a higher cumulative incidence of ARC or AIDS. These findings suggest that 90K is an early indicator of progression to ARC and AIDS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095982

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  16 in total

1.  Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.

Authors:  E C Darcissac; V Vidal; X De La Tribonniere; Y Mouton; G M Bahr
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children.

Authors:  B Gröschel; J J Braner; M Funk; R Linde; H W Doerr; J Cinatl; S Iacobelli
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

Review 3.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

4.  Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivo.

Authors:  M Trahey; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.

Authors:  Bing Sun; Linda Abadjian; Alexander Monto; Heather Freasier; Lynn Pulliam
Journal:  J Infect Dis       Date:  2020-07-06       Impact factor: 5.226

Review 6.  90K (Mac-2 BP) and galectins in tumor progression and metastasis.

Authors:  Antonino Grassadonia; Nicola Tinari; Ida Iurisci; Enza Piccolo; Alba Cumashi; Pasquale Innominato; Maurizia D'Egidio; Clara Natoli; Mauro Piantelli; Stefano Iacobelli
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

7.  Human milk galectin-3 binding protein and breast-feeding-associated HIV transmission.

Authors:  Christina S Chan; Hae-Young Kim; Chloe Autran; Jae H Kim; Moses Sinkala; Chipepo Kankasa; Mwiya Mwiya; Donald M Thea; Grace M Aldrovandi; Louise Kuhn; Lars Bode
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

Review 8.  Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer
Journal:  Genetica       Date:  1995       Impact factor: 1.082

Review 9.  Cellular Antiviral Factors that Target Particle Infectivity of HIV-1.

Authors:  Christine Goffinet
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

Review 10.  A critical analysis of the HIV-T4-cell-AIDS hypothesis.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer; B Hedland-Thomas; B A Page
Journal:  Genetica       Date:  1995       Impact factor: 1.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.